XML 54 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Business segment information (Tables)
 12 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
Schedule of External Net Sales by SBU Reporting Segment

External Net Sales by SBU:

The table below presents external net sales for continuing operations by SBU reporting segment. Net sales include product sales and marketing service fees.

 

     External Net Sales by SBU
Year ended December 31,		  
(U.S. Dollars in thousands)    2013     2012     2011  
     Net Sales      Percent of
Total Net
Sales		     Net Sales      Percent of
Total Net
Sales		     Net Sales      Percent of
Total Net
Sales		  
     (Restated)     (Restated)     (Restated)  

BioStim

    $ 145,085         36 %    $ 174,562         40 %    $ 181,736         42 % 

Biologics

      53,746         14 %      53,731         12 %      42,910         10 % 

Extremity Fixation

      103,359         26 %      112,011         25 %      119,504         27 % 

Spine Fixation

      95,421         24 %      99,885         23 %      91,368         21 % 
  

 

 

     

 

 

    

 

 

     

 

 

    

 

 

     

 

 

  

Total Net Sales

 $ 397,611      100 %  $ 440,189      100 %  $ 435,519      100 % 
  

 

 

     

 

 

    

 

 

     

 

 

    

 

 

     

 

 

  
Summary of Net Margin, Defined as Gross Profit Less Sales And Marketing Expenses from Continuing Operations by SBU Reporting Segment

The table below presents net margin, defined as gross profit less sales and marketing expenses from continuing operations by SBU reporting segment:

 

Net Margin by SBU

(U.S. Dollars in thousands)

    Year Ended December 31,  
   2013      2012      2011  
     (Restated)      (Restated)      (Restated)  

Net Margin

         

BioStim

    $ 63,847       $ 88,788       $ 92,860   

Biologics

      24,794         23,589         18,978   

Extremity Fixation

      23,704         34,554         30,773   

Spine Fixation

      4,329         15,256         13,037   

Corporate

      (1,443 )       (1,495 )       (1,700 ) 
  

 

 

     

 

 

     

 

 

  

Total net margin

 $ 115,231    $ 160,692    $ 153,948   

General & administrative

   64,830      53,650      64,785   

Research and development

   26,768      28,577      22,861   

Amortization of intangible assets

   2,687      2,298      2,550   

Costs related to the accounting review and restatement

   12,945      —       —    

Impairment of goodwill

   19,193      —       —    

Charges related to U.S. Government resolutions

   —       1,295      57,141   
  

 

 

     

 

 

     

 

 

  

Operating (loss) income

 $ (11,192 )  $ 74,872    $ 6,611   
  

 

 

     

 

 

     

 

 

  

Schedule of Depreciation and Amortization by SBU Reporting Segment

The table below presents external net sales for continuing operations by SBU reporting segment. Net sales include product sales and marketing service fees.

 

     External Net Sales by SBU
Year ended December 31,		  
(U.S. Dollars in thousands)    2013     2012     2011  
     Net Sales      Percent of
Total Net
Sales		     Net Sales      Percent of
Total Net
Sales		     Net Sales      Percent of
Total Net
Sales		  
     (Restated)     (Restated)     (Restated)  

BioStim

    $ 145,085         36 %    $ 174,562         40 %    $ 181,736         42 % 

Biologics

      53,746         14 %      53,731         12 %      42,911         10 % 

Extremity Fixation

      103,359         26 %      112,011         25 %      119,504         27 % 

Spine Fixation

      95,421         24 %      99,885         23 %      91,368         21 % 
  

 

 

     

 

 

    

 

 

     

 

 

    

 

 

     

 

 

  

Total Net Sales

 $ 397,611      100 %  $ 440,189      100 %  $ 435,519      100 % 
  

 

 

     

 

 

    

 

 

     

 

 

    

 

 

     

 

 

  
Summary of Net Sales by Geographic Destination

The following geographic data includes net sales by geographic destination:

 

(U.S. Dollars in thousands)

    2013      2012      2011  
     (Restated)      (Restated)      (Restated)  

U.S.

    $ 293,032       $ 327,228       $ 322,186   

Italy

      16,755         18,742         17,447   

U.K.

      10,002         8,431         8,206   

Brazil

      26,786         31,166         34,424   

Others

      51,036         54,622         53,256   
  

 

 

     

 

 

     

 

 

  

Total net sales

 $ 397,611    $ 440,189    $ 435,519   
  

 

 

     

 

 

     

 

 

  

Analysis of Property, Plant and Equipment of Reporting Segments by Geographic Area

Analysis of property, plant and equipment by geographic area:

 

(U.S. Dollars in thousands)

    2013      2012  
     (Restated)      (Restated)  

U.S.

    $ 39,287       $ 38,504   

Italy

      8,150         7,625   

U.K.

      1,871         1,402   

Brazil

      3,210         3,421   

Others

      1,854         1,841   
  

 

 

     

 

 

  

Total

 $ 54,372    $ 52,793